A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Sichuan Enray Pharmaceutical Sciences Company
NGM Biopharmaceuticals, Inc
Elevation Oncology
Intensity Therapeutics, Inc.
Novartis
NantCell, Inc.
Hoffmann-La Roche
Montefiore Medical Center
Five Prime Therapeutics, Inc.
Ipsen
Stanford University
Icahn School of Medicine at Mount Sinai
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
INSYS Therapeutics Inc
Verastem, Inc.